The present study aimed to evaluate the effect of DPP-4 inhibitors on sMMSE scores, serum BDNF, and PTX-3 levels in patients with type 2 diabetes, compared with patients who only use metformin treatment. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.